April 2022

A String of Clinical Pearls for Immunotherapy in Non−Small Cell Lung Cancer

April 26, 2022

An expert panel engaged the audience in a live virtual symposium and case discussion on immune checkpoint inhibitors (ICIs) in the first-line treatment of non−small cell lung cancer (NSCLC) at the 2021 ASHP Midyear Clinical Meeting.